International Patent: ANTIBODIES TARGETING C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) PROTEIN, AND USES THEREOF

GENEVA, Sept. 24 -- IOMX THERAPEUTICS AG filed a patent application (EP2026/057466) for “ANTIBODIES TARGETING C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) PROTEIN, AND USES THEREOF”. With publication no. WO/2026/195655, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....